Literature DB >> 18444445

Relationship between fentanyl dosage and immune function in the postoperative period.

Israel Z Yardeni1, Benzion Beilin, Eduard Mayburd, Yifat Alcalay, Hanna Bessler.   

Abstract

BACKGROUND: Anesthesia and surgery are associated with impairment of the immune system expressed as an excessive proinflammatory immune response and suppression of cell mediated immunity. Opioids, an integral part of anesthetic technique, possess an inhibitory effect on both humoral and cellular immune responses. It was the aim of the present study to examine the effect of various doses of fentanyl on cytokine production during the perioperative period. INTERVENTION: The effect of large (LDFA, 70-100 microg/kg), intermediate (IDFA, 23-30 microg/kg) and small (SDFA, 2-4 microg/kg) doses of fentanyl on the immune function in the postoperative period was investigated. PARTICIPANTS: Sixty patients, randomly assigned to one of the three groups according to the dose of fentanyl were included in the study.
METHODS: The ex vivo secretion of IL-1beta, IL-2, IL-6, and IL-10 and NK cell cytotoxicity (NKCC) of peripheral blood mononuclear cells (PBMC) was tested before, and at 24, 48, and 72 hours following surgery.
RESULTS: The pattern of postoperative secretion of the proinflammatory cytokines IL-1beta and IL-6 and that of the anti-inflammatory cytokine IL-10 differed significantly between patients receiving SDFA and those receiving IDFA and LDFA, but was similar between the last two groups. A similar suppression of NKCC and IL-2 secretion was observed in the three groups.
CONCLUSIONS: The diminished proinflammatory cytokine response observed in patients treated by LDFA and IDFA suggests that although more stable immune function can be achieved by those methods in comparison with SDFA, it is recommendable to apply IDFA to avoid the side effects that might be observed using LDFA method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444445     DOI: 10.5055/jom.2008.0005

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  24 in total

1.  Regional anesthesia/analgesia and the risk of cancer recurrence and mortality after prostatectomy: a meta-analysis.

Authors:  Brenda M Lee; Vinny Singh Ghotra; Jose A Karam; Mike Hernandez; Greg Pratt; Juan P Cata
Journal:  Pain Manag       Date:  2015-08-07

2.  Suppression of Human Natural Killer Cells by Different Classes of Opioids.

Authors:  Dermot P Maher; Deepa Walia; Nicola M Heller
Journal:  Anesth Analg       Date:  2019-05       Impact factor: 5.108

3.  Comparative effects of flurbiprofen and fentanyl on natural killer cell cytotoxicity, lymphocyte subsets and cytokine concentrations in post-surgical intensive care unit patients: prospective, randomized study.

Authors:  Hajime Narahara; Yuji Kadoi; Hiroshi Hinohara; Fumio Kunimoto; Shigeru Saito
Journal:  J Anesth       Date:  2013-03-30       Impact factor: 2.078

4.  Interleukin-1 signaling in the basolateral amygdala is necessary for heroin-conditioned immunosuppression.

Authors:  Lee W Hutson; Christina L Lebonville; Meghan E Jones; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2017-01-25       Impact factor: 7.217

Review 5.  Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients.

Authors:  Michael A Smith; Maho Hibino; Bonnie A Falcione; Katherine M Eichinger; Ravi Patel; Kerry M Empey
Journal:  Ann Pharmacother       Date:  2013-11-04       Impact factor: 3.154

6.  Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation.

Authors:  Lee W Hutson; Jennifer L Szczytkowski; Timothy B Saurer; Christina Lebonville; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2014-01-24       Impact factor: 7.217

Review 7.  Opioids and infections in the intensive care unit should clinicians and patients be concerned?

Authors:  Craig R Weinert; Shravan Kethireddy; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-05       Impact factor: 4.147

Review 8.  Can regional anesthesia and analgesia prolong cancer survival after orthopaedic oncologic surgery?

Authors:  Juan P Cata; Mike Hernandez; Valerae O Lewis; Andrea Kurz
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

Review 9.  The Relationship Between Regional Anesthesia and Cancer: A Metaanalysis.

Authors:  Ravi K Grandhi; Samuel Lee; Alaa Abd-Elsayed
Journal:  Ochsner J       Date:  2017

10.  Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial.

Authors:  Jae Hee Woo; Hee Jung Baik; Chi Hyo Kim; Rack Kyung Chung; Dong Yeon Kim; Guie Yong Lee; Eun Hee Chun
Journal:  J Korean Med Sci       Date:  2015-09-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.